Project Grant R01AI180079
Award Date 9/10/25
Completion Date 8/31/29
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60611, USA
Similar Awards
- This Project Grant award of $464,615 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports a study to identify facilitators and barriers to pediatric food allergy management among Latino families in Providence, Rhode Island. The study will use a mixed-methods approach, including Geographic Information Systems analysis to evaluate contextual factors associated with food allergy-related emergency department use, as well...
- This $250,000 Project Grant was awarded on August 21, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The grant supports research to develop a prognostic signature of systemic immune dynamics for IgE/Th2-mediated food allergies, using a novel synthetic immunological niche technology. The goal is to distinguish the heterogeneity of allergic responses and monitor immune responses to...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $151,444 to The Children's Hospital of Philadelphia (CHOP) to study the development of pediatric allergic diseases and create allergy prediction models using electronic health record (EHR) data. The overarching goal is to improve outcomes in pediatric allergy by understanding the heterogeneous "allergic...
- This federal Project Grant award of $586,250 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research at the University of Massachusetts Medical School (UMass Medical) to investigate the generation and regulation of TFH13 cells that drive pathogenic IgE in allergic conditions. The overarching goal is to elucidate the pathways leading to TFH13 cell differentiation, which play a critical...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $147,486 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Mayo Clinic Arizona, a nonprofit academic medical center located in Scottsdale, Arizona. The grant, awarded from November 1, 2025 through April 30, 2027, supports research to better understand the mechanisms by which oral exposure to food antigen protects against the development of food allergy. The project aims to assess...
- This federal Project Grant award of $392,000 from the U.S. Department of Agriculture's (USDA) National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (AFRI) program will support research to investigate the use of immunoglobulin E (IgE) glycosylation as a replacement for oral food challenge tests in diagnosing food allergies. The research, led by Principal Investigator Dr. Jeff Sorelle, aims to: 1) analytically validate an IgE glycan test, 2) establish...
- This $195,696 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support the development, refinement, and evaluation of the Supportive Training in the Early Presentation of Food Allergens (STEP-FA) intervention. The goal of this 4-year project is to create an adaptive, behavioral intervention to improve caregiver adherence to recommendations for the early introduction of peanut and egg to infants,...
- This $612,917 federal Project Grant was awarded on July 23, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research by Seattle Children's Hospital, doing business as Seattle Children's Research Institute, to investigate the role of the SIGLEC-9 receptor in regulating mast cell function and its potential for therapeutic targeting to treat mast cell-associated disorders such as...
- This federal Project Grant award of $3,147,392.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand how dendritic cells initiate specific T helper (Th) cell responses to pathogens. The research aims to elucidate the innate sensing mechanisms by which dendritic cells drive the differentiation of Th1 versus Th17 lineage cells in response to distinct microbial...
- This federal Cooperative Agreement award for $401,250.00 was granted by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The purpose is to conduct research on "Antibiotics, Innate Immunity, and Dysbiosis in Pediatric Urticarial Reactions." The project aims to study antibiotic-associated reactions (AARs), including serum sickness-like reactions (SSLRs), which occur in 5-10% of children and cause...